Justification and experience of using ointments with immunomodulating properties in hemorrhoids and anal fissures
https://doi.org/10.21518/1995-1477-2019-1-2-124-130
Abstract
Acute and chronic hemorrhoids and coexisting conditions remain an important medical problem at the intersection of medical specialties. Among the proposed approaches to therapy is the use of immunomodulating agents, which allows to ensure the influence on several pathogenetic mechanisms of development and progression of the disease. Ointments containing bacterial cultural suspension of E. coli (BCS) as an active component have a solid experience in clinical practice and a strong evidence base, including meta-analysis of multicenter randomized trials.
About the Author
G. Yu. Knorring
Moscow State University of Medicine and Dentistry named after A.I. Yevdokimov of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Knorring German Yurievich – Candidate of Medical Sciences, Associate Professor of the Department of Therapy, Clinical Pharmacology and Emergency Medical Care.
127473, Moscow, 20, Delegateskaya St.
References
1. Shelygin Yu.A., Blagodarniy L.A. Reference book on coloproctology. M.: Literra, 2014: 597.
2. Corman M.L. Colon and rectal surgery. 5-th ed. Philadelfia: Lippincott, 2004:1741.
3. Ganz R.A. The evaluation and treatment of hemorrhoids: a guide for the gastroenterologist. Clin. Gastroenterol. Hepatol. 2013;11(6):593–603.
4. Goligher J.C. Surgery of the anus, rectum and colon. London: Balliere Tindal. 1980:93–135.
5. Riss S., Weiser F.A., Schwameis K., Riss T., Mittlböck M., Steiner G. et al. The prevalence of hemorrhoids in adults. Int J. Colorectal. Dis. 2012;27(2):215–220.
6. Vorobiev G.I., Shelygin Yu.A., Blagodarniy L.A. Hemorrhoids. 2nd edition M.: Literra, 2010: 188.
7. National clinical recommendations. Coloproctology. M.: GEOTAR-Media, 2015:30-53.
8. Knorring G.Yu. Application of a combination of tribenoside andlidocaine in thelocal treatment of hemorrhoids: a review of clinical studies. Doctor. Ru. 2017;2(131):63–68.
9. Besredka A. Dielokalelmmunisierung. Verlag Johannes Ambrosius Barth, Leipzig, 1926.
10. Bonnin L. Ober eine neuelokale Vakzinetherapie. Allgem Med Central Ztg. 1922, 91:185.
11. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004 October;5(10):987–995. doi: 10.1038/ni1112.
12. Kiseleva E.P. New ideas on anti-infectious immunity. Infection and immunity [Infekciya i immunitet]. 2011;1(1):9–14.
13. Everson M.P., McDuffie D.S., Lemak D.G., Koopman W.J., McGhee J.R., Beagley K.W. Dendritic cells from different tissues induce production of different T cell cytokine profiles. J Leukoc Biol. 1996;59(4):494-498.
14. Alexandrova M.V., Radchenko V.V., Lipkin V.M. E. coli inactivated bacterial cultural suspension is an active component of pharmacological preparations. Rational nutrition, nutritional supplements and biostimulants [Racional’noe pitanie, pishchevye dobavki i biostimulyatory.]. 2014;2:11-11.
15. Konig, W., König W., Kasimir S., Hensler T., Scheffer J. et al. Release of inflammatory mediators by toxin stimulated immune system cells and platelets. Zbl Bakt. 1992; 23 (Suppl):385–394.
16. Gebauer F., Ottendorfer D., Kunze R., Maasch H.J. Influence of a co-stimulation of humanleucocytes with an Escherichia coli preparation and fixed immunoglobulins on cytokine release in the presence of hydrocortisone. Arzneim.-Forsch./Drug Res. 2001;51(I):180-187. doi: 10.1055/s-0031-1300023.
17. Scheffer J., Konig W., Hacker J., Goebel W. Bacterial Adherence and Hemolysin Production from Escherichia coli Induces Histamine and Leukotriene Release from Various Cells. Infection and immunity. 1985; 50(1):271-278.
18. Kido H., Yasukawa H., Hirota T., Shindo A., Naruse T. Decrease in rat internal anal pressure with the use of a topical ointment containing a killed E. coli culture suspension. Int J. Colorectal Dis. 2007 Mar;22(3):271-276. doi: 10.1007/s00384-006-0123-8.
19. Frank W., Reichel U. Die konservative Behandlung der analen Kryptitis mit einer topischen Vakzine. Colo-proct. 1983;3:83.
20. Goltsche T.Z. Medikamentose Therapie haufiger anorektaler Beschwerden. Allgem Med. 1990;66:432.
21. Hagedorn M. Das Hamorrhoidalleiden – Erfahrungsbericht Ober eine kombinierte Suppositorien – Sklerosierungsbehandlung. Allgemein Med. 1982;58:1675.
22. Inagaki H., Kusama S., Hayashi F. Posterisan – PrOfung Ober den Effekt der Posterisan Salbe bei Hamorrhoiden im Doppelblindversuch. Jap Pharm Ther. 1974;2:103.
23. Lindhal G., Sjobring U., Johnsson E. Human complement regulators: a major target for pathogenic micro-organisms. Curr Opin lmmunol. 2000;12:44-51.
24. Wienert V., Heusinger J.H. еt al. Local treatment of hemorrhoidal disease and perianal eczema. Meta-analysis of the efficacy and safety of an Escherichia coli culture suspension alone or in combination with hydrocortisone. Arzncim.-Forsch./Drug Res. 2002;52(7):515-523. doi: 10.1055/s-0031-1299924.
25. Gainutdinov F.M., Khadyeva A.A., Khadyev R.F., Gumerova G.T. Comparative morphological analysis of efficacy of treatment of acute anal fissure. Perm Medical Journal [Permskij medicinskij zhurnal]. 2010;27(3):75-78.
26. Gainutdinov F.M., Gumerova G.T., Khadyeva A.A., Khadyev R.F. Complex treatment of patients with an anal fissure using immunomodulatory drugs. Materials of the International Joint Congress of the Association of Coloproctologists of Russia and the first ESCP/ECCO regional master class, April 16-18, 2015, Moscow. Coloproctology [Koloproktologiya.]. 2015;1(51) (attachments):19-20.
27. Nekhrikova S.V., Titov A.Yu., Veselov A.V. Influence of the drug on healing of postoperative wounds of the anal canal and perineum. Evidential gastroenterology [Dokazatel’naya gastroehnterologiya.]. 2017;2:59-65.
Review
For citations:
Knorring G.Yu. Justification and experience of using ointments with immunomodulating properties in hemorrhoids and anal fissures. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2019;(1-2):124-130. (In Russ.) https://doi.org/10.21518/1995-1477-2019-1-2-124-130
Views:
1403
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 